Marie Wikström Lindholm
Chief Tech/Sci/R&D Officer at SILENCE THERAPEUTICS PLC
Marie Wikström Lindholm active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2023-11-30 | - |
| Corporate Officer/Principal | 2020-11-01 | 2023-11-30 | |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | 2022-01-17 | - |
Career history of Marie Wikström Lindholm
Former positions of Marie Wikström Lindholm
| Companies | Position | Start | End |
|---|---|---|---|
| University of Lund | Corporate Officer/Principal | 1998-12-31 | 1999-12-31 |
Training of Marie Wikström Lindholm
| University of Uppsala | Doctorate Degree |
Statistics
International
| Sweden | 3 |
| United Kingdom | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private companies | 1 |
|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
